Loading…
Tuesday, September 29
 

09:00 CEST

Opening Remarks
Tuesday September 29, 2026 09:00 - 09:30 CEST
Inaugural speeches by the President of the Association and authorities
Speakers
avatar for Cristina Nadal Sanmartin

Cristina Nadal Sanmartin

Executive Director of Policy / President of AseBio, MSD
President of AseBio since December 2025.
Since July 2020, she has held the position of Executive Director of Policy & Government Affairs at the pharmaceutical company Merck, Sharp & Dohme de España, S.A.
Since December 2023, she has been Second Vice President of the Spanish Asso... Read More →
Tuesday September 29, 2026 09:00 - 09:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

10:15 CEST

Inside Spanish Biotech VC Playbooks: What Moves the Investment Needle
Tuesday September 29, 2026 10:15 - 11:00 CEST
Want to tilt the odds in your favor on the roadshow? Hear it straight from the source: Spain’s top biotech VCs will unveil their investment playbooks—how they judge scientific risk, vet team credentials and experience, assess development plans, and prioritise therapeutic areas. Each investor gets a brisk, 9-minute spotlight to explain what truly moves the needle. Walk away with a sharper sense...
See More →
Moderators
avatar for Guillermo Serrano

Guillermo Serrano

PartNer, Checkpoint Partners

Speakers
avatar for Arturo Urrios

Arturo Urrios

Partner, Ysios Capital
Arturo leads early-stage investments and company creation at Ysios Capital, driving the firm’s early-stage initiative.Previously, he worked at M Ventures and most recently at Wellington Parties, where he was involved in multiple financings including Riffyn (acquired by Siemens... Read More →
avatar for Tracy Weightman

Tracy Weightman

Associate Director, Deep Science Ventures (Montana Children's Health Venture Fund)

avatar for Laura Rodríguez Gallego

Laura Rodríguez Gallego

Partner, Invivo Partners

avatar for Clara Campás

Clara Campás

Managing partner and co-founder of Asabys, Asabys Partners
Managing partner and co-founder of Asabys. Clara currently serves on the board of directors of Ona Therapeutics, Nuage Therapeutics, ALLOX and Augustine Therapeutics.Formerly, Clara served as Strategy & Development Director at Kern Pharma and held several positions at Advancell, including... Read More →
avatar for María Poveda

María Poveda

Director Alternative Assets I Life Sciences, Inveready
María joined Inveready in 2018, she is responsible of identifying investment opportunities and leading the investment process. She has actively contributed to the construction of Inveready Biotech III’s portfolio. Furthermore, she provides support and monitors the performance of... Read More →
Tuesday September 29, 2026 10:15 - 11:00 CEST
4 Raúl Martín room

10:15 CEST

Biologics as Strategic Capability: Europe's Production Base in a New Security Era
Tuesday September 29, 2026 10:15 - 11:00 CEST
The ongoing challenges at Europe's borders and beyond, the lingering effects of COVID-19, and the shifting landscape of biological threats have fundamentally reshaped the way Europe must approach its biologic sector. Vaccines, therapeutics, and diagnostics are no longer just healthcare solutions, they are essential strategic assets. Europe's ability to produce these tools quickly, at scale, and on...
See More →
Speakers
avatar for Maria Christina Stavridou

Maria Christina Stavridou

Head of Vaccine & Immunisation Programmes Commercial, Vaccines & Countermeasures Delivery Chief Operating Officer Group, UKHSA (UK Health Security Agency)
Economist and public sector leader with experience across government, multilateral organisations, and consulting/advisory roles in 10+ countries. I currently lead vaccine planning and supply within the UK’s routine immunisation programmes, overseeing procurement, stock management... Read More →
avatar for Carlota Gómez de la Hoz

Carlota Gómez de la Hoz

Chief Corporate Affairs & Sustainability Officer, LABORATORIOS HIPRA S.A.

avatar for Ceri Morgan

Ceri Morgan

Trade Commissioner Europe, Department for Business and Trade (UK Government)
Ceri Morgan is His Majesty’s Trade Commissioner for Europe, with responsibility for encouraging trade and investment between the UK and other European countries, as well as Israel. In her most recent position, she led the Department for Environment, Food and Rural Affairs... Read More →
avatar for Tomasz Husak

Tomasz Husak

Director for Defence Policy, DG DEFIS (Defence Industry and Space - European Commission)
Tomasz Husak is Director of Directorate A – Defence Policy in the Directorate General for Defence Industry and Space (DG DEFIS) since 16 February 2026. Husak has 20 years of experience in defence and space policy, economics and international relations. Prior to joining the Commission... Read More →
Tuesday September 29, 2026 10:15 - 11:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

10:15 CEST

From Strategy to Collective Action: Building Europe's Agri-Food Biotech Ecosystem Together
Tuesday September 29, 2026 10:15 - 11:00 CEST
Europe has no shortage of ambitious strategies for biotechnology. The challenge now is implementation.Delivering a competitive, resilient and sustainable European agri-food biotechnology ecosystem will require coordinated action across industry, startups, academia, investors, farmers, policymakers and innovation organisations. No single stakeholder can deliver this transformation alone.This...
See More →
Moderators
avatar for Lorena Savani

Lorena Savani

EIT Food Director of Biotech and Protein Thematic Leadership, EIT Food

Speakers
avatar for Angela Sessitsch

Angela Sessitsch

Head of Health & Bioresources, AIT Austrian Institute of Technology

avatar for Patricia Larráyoz Lorea

Patricia Larráyoz Lorea

Spain’s AgriFoodTech Sandbox Manager, CNTA

Tuesday September 29, 2026 10:15 - 11:00 CEST
3 Nicolás Achúcarro room

11:00 CEST

Coffee break
Tuesday September 29, 2026 11:00 - 11:30 CEST

Tuesday September 29, 2026 11:00 - 11:30 CEST
4 Raúl Martín room

11:00 CEST

Coffee break
Tuesday September 29, 2026 11:00 - 11:30 CEST

Tuesday September 29, 2026 11:00 - 11:30 CEST
2 Dorotea Barnés room

11:00 CEST

Coffee break
Tuesday September 29, 2026 11:00 - 11:30 CEST

Tuesday September 29, 2026 11:00 - 11:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:00 CEST

Coffee break
Tuesday September 29, 2026 11:00 - 11:30 CEST

Tuesday September 29, 2026 11:00 - 11:30 CEST
3 Nicolás Achúcarro room

11:30 CEST

Progress and challenges of advanced therapies for rare diseases
Tuesday September 29, 2026 11:30 - 12:00 CEST
Dr. Bueren leads the Biomedical Innovation Unit at CIEMAT and also conducts research at CIBERER and the Jiménez Díaz Foundation Health Research Institute. Throughout his career, he has made decisive contributions to the development of new gene and cell therapies targeting rare and hereditary diseases, driving the translation of research from the laboratory to clinical practice.Internationally...
See More →
Speakers
avatar for Juan A. Bueren Roncero

Juan A. Bueren Roncero

Director Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT)
Head of the Division of Innovative Therapies in the Hematopoietic System at CIEMAT and CIBER of Rare Diseases of the ISCIII, as well as Coordinator of the Joint Unit for Advanced Therapies CIEMAT/IIS-Jiménez Díaz Foundation. Vice President of the ESGCT.
Tuesday September 29, 2026 11:30 - 12:00 CEST
2 Dorotea Barnés room

11:30 CEST

Choosing the Basque Country to grow your business in life sciences and health – discover the reasons
Tuesday September 29, 2026 11:30 - 12:15 CEST
Since the launch of the BioBasque strategy in 2002, Euskadi has invested in consolidating an innovation ecosystem which supports the growth of the health and life sciences industry. Under the overarching strategy of clusters as models for growth of sophisticated sectors, a sustained institutional support and the public-private collaboration have leveraged the development of a growing industry...
See More →
Moderators
avatar for María Aguirre

María Aguirre

Head of Health and Sociohealth transition, SPRI

Speakers
avatar for Fermin Goytisolo

Fermin Goytisolo

Founder ITUA H., Eikonoklastes Therapeutics / ITUA HEALTH

avatar for Lourdes Basabe

Lourdes Basabe

Principal Investigator. Leader of the BIOMICs microfluidics Team, University of the Basque Country
Independent researcher interested in the field of micro bioengineering and lab-on-a-chip technologies. Ikerbasque Research Professor since 2012, Director of the Microfluidics & BIOMICS Cluster UPV/EHU since 2019, Principal Investigator of the BIOMICS-microfluidics Research team since... Read More →
avatar for Iñaki Gutiérrez Ibarluzea

Iñaki Gutiérrez Ibarluzea

Director of Health Research, Innovation and Evaluation, Health Service of the Basque Country

avatar for Javier García Cogorro

Javier García Cogorro

General Partner, Columbus Venture Partners
Founding Partner at Columbus Venture Partners, Javier García spent 25 years at Eli Lilly and Company, where he held various executive positions in Business Development and Information Systems. Since 2009, he has focused on venture capital investment, particularly in private comp... Read More →
avatar for Idoia Muñoz Lizán

Idoia Muñoz Lizán

Managing Director, Basque Health Cluster (BHC)

Tuesday September 29, 2026 11:30 - 12:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:30 CEST

What’s the Secret Sauce Behind a Successful Spin-off?
Tuesday September 29, 2026 11:30 - 12:15 CEST
Key success factors behind high-performing spin-offs, including team, science, funding strategy and execution. What to take into account in the early stages to move fast, de-risk projects and build strong foundations for growth. Insights and lessons learned from real cases and different stakeholder perspectives.
Moderators
avatar for Anna Bellmunt

Anna Bellmunt

Senior Associate, Asabys Partners
Senior Associate at Asabys, where she joined in 2021, Anna is responsible for sourcing and assessing opportunities from the scientific, development and business perspectives. Anna currently serves as a board observer at Ona Therapeutics and Nuage Therapeutics.Previously, Anna was... Read More →
Speakers
avatar for Agnés Arbat

Agnés Arbat

Spanish biotech founder, Oxolife

avatar for Gustavo Fuster

Gustavo Fuster

IP lawyer, Hoffmann Eitle
Gustavo Fúster is a patent professional with over 15 years of experience within the field of life sciences patents.

Gustavo first worked as an in-house IP manager and patent specialist in a Spanish biotech firm which provided him with experience in the field of monoclonal antibod

... Read More →
avatar for Etienne Drouet

Etienne Drouet

Vice President, Client Partner & Adviser for Biotech & Venture Capitals, IQVIA
33 years experience in Drug Development in Pharmaceutical industry, Biotech, Contract Research Organisation and Investigational Cooperative Groups.

Specialties: 
- Drug Development in Biotechnology, Oncology, precision medicine & gene therapy, Early Phase Development,
- Project Man



... Read More →
avatar for Marcos Simón

Marcos Simón

Head of TTO, CIC Biomagune

Tuesday September 29, 2026 11:30 - 12:15 CEST
4 Raúl Martín room

11:30 CEST

Startup pitch presentations: Bioeconomy
Tuesday September 29, 2026 11:30 - 12:15 CEST
Meet innovative startups that are seeking funding to address some of the key challenges of our society. From global warming to the challenge of feeding more than 8 billion people or the need to manage waste and byproducts, biotechnology is offering creative solutions and alternatives.Start-ups will have the opportunity to present their business plans to a panel of investors. Attendees will be...
See More →
Speakers
avatar for Helena García Cebollada

Helena García Cebollada

CEO, BioPredX
Helena García Cebollada (she/her) is the CEO of BioPredX. After getting her PhD in Bioinformatics in 2022, she continued developing predictive software for proteins and genetic variants in her postdoctoral work. This was the starting seed for BioPredX, which she founded in 2026 in... Read More →
avatar for Pablo Montequín

Pablo Montequín

CEO & Co-founder, Calfix
Entrepreneur and legal professional with a Master’s in Intellectual Property & Technology, bringing a proven track record in driving industrial, biotech, and tech projects across Latam, Ireland, and Israel. Heads strategic growth and fundraising initiatives, bridging the gap between... Read More →
avatar for Josune Ayo

Josune Ayo

CEO, Genbioma
Josune Ayo, Ph.D., CEO and co-founder of Genbioma. Ph.D. in Food Technology (UCM) with over 25 years of experience in food innovation. Research background includes 40 publications and four patents, focused on developing foods with nutritional and health benefits. Active member of Food and... Read More →
avatar for Antxon Caballero

Antxon Caballero

CEO, Heuristik
Antxon is a serial entrepreneur with a successful exit. Antxon studied administration and finances with a masters in Big Data, he has international experience in sales and project management, he co founded Heuristik 6 years ago when a nurse made a wrong identification error to his... Read More →
avatar for Mariano Oto

Mariano Oto

CEO, Nucaps
Mariano Oto. Bachelor’s Degree in Economics and Business Sciences, with postgraduate studies in international trade. Entrepreneur and senior executive with more than 20 years of experience in business leadership, commercial strategy, and innovation management. Since 2017, CEO of... Read More →
avatar for Jordi Sarrà

Jordi Sarrà

Head of Business Development, Cocoon Bioscience
Jordi Sarrà is Head of Business Development at Cocoon Bioscience. With more than 20 years of experience in the pharmaceutical and biotech sectors, he specializes in strategic partnerships, licensing, and international business development. He combines a scientific background in Human... Read More →
Tuesday September 29, 2026 11:30 - 12:15 CEST
3 Nicolás Achúcarro room

12:15 CEST

Beyond Discovery: How AI, Advanced Therapeutics and Clinical Evidence Are Reshaping Biotech Innovation
Tuesday September 29, 2026 12:15 - 13:00 CEST
The biotechnology sector is entering a new era in which innovation is no longer driven by scientific discovery alone. The increasing convergence of artificial intelligence, advanced therapeutic approaches, and data-driven clinical decision-making is fundamentally transforming the way new healthcare solutions are conceived, developed, validated, and ultimately delivered to patients. As scientific...
See More →
Moderators
AG

Andrea García Vicente

Director, ABIOINNOVA

Speakers
avatar for Teresa Ruiz Herrero

Teresa Ruiz Herrero

Associate Director Digital Health and RWE, Almirall
I am a dynamic leader and interdisciplinary scientist with over a decade of experience driving innovation at the intersection of technology, healthcare, and strategy. My expertise spans computational modeling, digital health, biomarker discovery, and forging strategic partnerships... Read More →
avatar for Juan Sebastián Ruiz

Juan Sebastián Ruiz

CEO, APTADEGRAD
CEO de Aptadegrad y Lincbiotech.  Licenciado y basado en Madrid/Santiago de Compostela, lidera la spin-off biomédica Lincbiotech  del IDIS especializada en el diagnóstico y tratamiento de enfermedades neurológicas graves (como el Alzheimer y el ictus) utilizando intelige... Read More →
avatar for Alejandro Martí

Alejandro Martí

CEO, Votum Labs
Alejandro Martí, junto a Borja Vera, fundó Votum Laboratorios en 2021 con el objetivo de transformar la salud y el bienestar a través de cannabinoides seguros, eficaces y avalados por la ciencia. En apenas tres años, la empresa ha lanzado varias líneas de producto propias para personas y mascotas, certificado su... Read More →
avatar for Manuel Vielma

Manuel Vielma

CEO, E-PISTEME
Manuel Vielma, CEO y fundador de E-Pisteme, startup edTech de la Comunidad LN, trabajan impulsando el aprendizaje STEM a través de experiencias inmersivas, tecnología y creatividad. Gracias a soluciones como E-Tellurion, su kit interactivo sobre el sistema solar, los estudiantes... Read More →
Tuesday September 29, 2026 12:15 - 13:00 CEST
2 Dorotea Barnés room

12:15 CEST

Europe’s Biotech Moment: What the Biotech Act Must Deliver
Tuesday September 29, 2026 12:15 - 13:00 CEST
The year 2025 has been marked by the Biotech Act, the proposed Regulation through which the European Commission aims to establish a comprehensive regulatory framework to foster investment, innovation, and competitiveness in the biotechnology sector at a pivotal moment for Europe's strategic autonomy.Against this backdrop, this session will explore how the Biotech Act represents an opportunity to...
See More →
Moderators
avatar for Laura Pellísé

Laura Pellísé

Government Affairs Director, Amgen

Speakers
avatar for Cristina Nadal Sanmartin

Cristina Nadal Sanmartin

Executive Director of Policy / President of AseBio, MSD
President of AseBio since December 2025.
Since July 2020, she has held the position of Executive Director of Policy & Government Affairs at the pharmaceutical company Merck, Sharp & Dohme de España, S.A.
Since December 2023, she has been Second Vice President of the Spanish Asso... Read More →
avatar for Javier Padilla Bernáldez

Javier Padilla Bernáldez

Secretary of State, Ministry of Health

Tuesday September 29, 2026 12:15 - 13:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

12:15 CEST

Startup Pitch Presentations: Oncology
Tuesday September 29, 2026 12:15 - 13:15 CEST
Companies seeking funding to develop treatments in neurology and oncology will present their companies and pitch their business opportunity.Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.Ability Pharmaceuticals, SA  – Carles Domènech, CEOInnoup Farma Kinsy, S.l.  –  Elisa Longás, Chief...
See More →
Speakers
avatar for Carles Domènech

Carles Domènech

CEO, Ability Pharma, S.A.
Carles Domènech, PhD, is Executive Chairman, CEO and co-founder of AbilityPharma, with 30+ years of international experience in biotech, pharma business development, licensing and venture capital. He holds a Biology degree and PhD from Universitat Autònoma de Barcelona, plus business... Read More →
avatar for Elisa Longás

Elisa Longás

Chief Business Officer, Innoup Pharma
Elisa Longás is Chief Business Officer at InnoUp Farma, where she leads corporate strategy, business development and global partnering initiatives. She combines scientific and biotech & pharmaceutical business expertise to drive strategic growth opportunities and international collaborations... Read More →
avatar for Cristina Aguilera

Cristina Aguilera

CEO, Labsinlove
Cristina Aguilera Xiol, PhD MBM, is CEO of Labsinlove and has an international background in biotechnology, translational medicine and innovation management. She started her career in academia as a researcher and later worked internationally across both academia and industry, including... Read More →
avatar for Ana Bouchet

Ana Bouchet

CEO, Lifesome Therapeutics, S.L.
Ana Bouchet is the Co-founder and CEO of Lifesome Therapeutics. She holds a degree in Biotechnology and a PhD in Lipid Biophysics. Her research interests include nanotechnology, molecular delivery, and biophysics applied to biomaterials. In 2022, she spearheaded the company’s growth... Read More →
avatar for Andri Leonidou

Andri Leonidou

Head Of Bi And Corporate Affairs, Nuage Therapeutics
Andri Leonidou is Head of Business Intelligence and Corporate Affairs at Nuage Therapeutics, responsible for competitive intelligence, partnership assessments, and strategic insights to support the company's pipeline and business development activities. She holds a PhD in breast cancer... Read More →
avatar for Teresa Rodríguez-Carmona García

Teresa Rodríguez-Carmona García

Business Development Associate, Oncomatryx Biopharma SA
Teresa is a business development associate at Oncomatryx Biopharma S.A. since October 2025. She supports BD activities by contributing to strategic partnerships, market analysis and stakeholder engagement for preclincial and clinical programs. Teresa holds a Bsc (Honours) in Biomedical... Read More →
avatar for Jesús Martin Garcia

Jesús Martin Garcia

CEO, Peptomyc, S.L.
Jesús Martín García is CEO of Peptomyc, with over two decades of leadership in drug development, biotech strategy and corporate finance. He has held CEO and Board roles, leading clinical-stage programs, partnering transactions and capital raises from Series A through IPO. He holds... Read More →
avatar for Marta Compte Grau

Marta Compte Grau

R&D Director, Trimerbody Pharma
Marta Compte Grau MD, PhD Immunologist and biotech executive with more than 15 years of experience in immuno-oncology, antibody engineering and translational development of biologics. Currently leading scientific, operational and strategic activities at Trimerbody Pharma, advancing... Read More →
Tuesday September 29, 2026 12:15 - 13:15 CEST
4 Raúl Martín room

13:00 CEST

Lunch Break
Tuesday September 29, 2026 13:00 - 14:30 CEST

Tuesday September 29, 2026 13:00 - 14:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

13:00 CEST

Lunch Break
Tuesday September 29, 2026 13:00 - 14:30 CEST

Tuesday September 29, 2026 13:00 - 14:30 CEST
2 Dorotea Barnés room

13:00 CEST

Lunch Break
Tuesday September 29, 2026 13:00 - 14:30 CEST

Tuesday September 29, 2026 13:00 - 14:30 CEST
3 Nicolás Achúcarro room

13:15 CEST

Lunch Break
Tuesday September 29, 2026 13:15 - 14:30 CEST

Tuesday September 29, 2026 13:15 - 14:30 CEST
4 Raúl Martín room

14:30 CEST

Boosting biotechnology development accelerators
Tuesday September 29, 2026 14:30 - 15:15 CEST
The Biotech Act will establish the first comprehensive framework to promote biotechnology as a strategic sector for the European Union’s competitiveness, public health, sustainability, and technological autonomy. The law aims to position Europe in the global competition with the United States and China in this strategically important field.About fostering biotechnology startup companies in the...
See More →
Moderators
avatar for Amelia Martín Uranga

Amelia Martín Uranga

Director of Clinical and Translational Research, FARMAINDUSTRIA
Amelia Martín Uranga, PhD in Law, Director of Clinical and Translational Research and Head of the Innovative Medicines Platform (Farmaindustria), focuses primarily on the implementation and management of public-private partnership projects, such as the BEST Project and the Pharma-Biotech... Read More →
Speakers
avatar for María José Lallena Jimeno

María José Lallena Jimeno

Director of the Research, Development and Innovation Center, Lilly España
Doctora en Bioquímica y Biología Molecular por la Universidad Autónoma de Madrid. Su trayectoria profesional se inició con dos periodos postdoctorales: el primero de ellos en el Centro de Biología Molecular de Madrid y el segundo, en el Laboratorio Europeo de Biología Molecular... Read More →
avatar for Idoia Muñoz Lizán

Idoia Muñoz Lizán

Managing Director, Basque Health Cluster (BHC)

avatar for Núria Martí

Núria Martí

Director of Innovation and Business Development, Biocat
Núria Martí Ras has an undergraduate degree in Veterinary Sciences (Autonomous University of Barcelona, 1993), PhD in Veterinary Sciences (UAB, 1999), master’s in Laboratory Animal Science and Welfare (UAB, 2009) and a master’s in R&D Management in Health from the Carlos III... Read More →
avatar for Javier Jiménez

Javier Jiménez

Chief Medical Officer, Pharmamar
Experienced healthcare professional with over two decades of experience leading evidence generation strategies and research at some of the world’s most prestigious pharmaceutical and health technology companies. As Chief Medical Officer at PharmaMar, I drive the integration clinical... Read More →
avatar for Marisol Quintero

Marisol Quintero

COO, Highlight Therapeutics

Tuesday September 29, 2026 14:30 - 15:15 CEST
2 Dorotea Barnés room

14:30 CEST

From Zero to GMP
Tuesday September 29, 2026 14:30 - 15:15 CEST
The Decisions Behind Long-Term SuccessTwenty years ago, 3PBIOVIAN was founded with a clear purpose: to advance global health by helping innovators bring new therapies to patients. Today, the company is a GMP manufacturing partner supporting healthcare innovators around the world.What happened in between was neither luck nor a straight path to success. It was the result of deliberate decisions made...
See More →
Moderators
avatar for Elena Erroba Esquiroz

Elena Erroba Esquiroz

Chief Commercial Officer, 3PBiovian

Speakers
GD

Guido Dietrich

External Consultant

avatar for Javier López Moras

Javier López Moras

Partner, Keensight Capital
Javier is a Partner at Keensight Capital, where he focuses on covering the Spanish market.Prior to Keensight, Javier spent almost 10 years as an M&A advisor in Madrid and London at DC Advisory where he was a Director in the Financial Sponsors & Debt Advisory Practice. He was responsible... Read More →
avatar for Dámaso Molero Sánchez

Dámaso Molero Sánchez

Group Chief Executive Officer, 3PBiovian
Experienced General Manager with a demonstrated successful history of more than 34 years working in Pharma and Biotechnology industry. Plant Director, Qualified Person and others. Member of Executive Board of ASEBIO (Spanish Asociation of Bio Companies) Member as an expert of "High-Level... Read More →
Tuesday September 29, 2026 14:30 - 15:15 CEST
3 Nicolás Achúcarro room

14:30 CEST

Joint Opportunities for the UK and Spain through Horizon Europe Collaborations.
Tuesday September 29, 2026 14:30 - 15:15 CEST
As the Guest Nation of BIOSPAIN 2026, the United Kingdom takes centre stage in this high-level round table exploring how UK–Spain collaboration can drive innovation, competitiveness and growth across the life sciences sector through Horizon Europe. Bringing together leading British and Spanish voices from across biotech, research, innovation and public-sector collaboration, this session will...
See More →
Speakers
avatar for Marcel de Matas

Marcel de Matas

Founder & Chief Business Officer, Seda Pharmaceutical Development & Clinical Manufacturing Services
Marcel is Founder and Chief Business Officer at Seda, a company focussed on delivering chemistry manufacturing and controls (CMC) and clinical pharmacology services. The company is located in Cheadle, Stockport and supports companies across UK, Europe, US, Asia and Australia.

Marcel has led the growth of technical capabilities and services at Seda, and has been instrumental in its transformation from a consultancy based business to an internationally recognised contract research, development, and manufacturing organisation. Services include the development

... Read More →
avatar for Ceri Morgan

Ceri Morgan

Trade Commissioner Europe, Department for Business and Trade (UK Government)
Ceri Morgan is His Majesty’s Trade Commissioner for Europe, with responsibility for encouraging trade and investment between the UK and other European countries, as well as Israel. In her most recent position, she led the Department for Environment, Food and Rural Affairs... Read More →
Tuesday September 29, 2026 14:30 - 15:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

14:30 CEST

Spanish biotech spin-offs and their integration into the global ecosystem: reaching out and attracting EU, US and Asia players
Tuesday September 29, 2026 14:30 - 15:15 CEST
Spanish biotech spin-offs are stepping onto the global stage like nimble launchpads of innovation, pulling in investors and partners from Europe, the US and Asia. Rooted in world-class science yet built for translation, they marry academic brilliance with entrepreneurial grit — and with sharper international branding, smoother regulatory pathways and bolder cross-border alliances, they can turn...
See More →
Moderators
avatar for Emilio Erazo Fischer

Emilio Erazo Fischer

Operating Partne, Asabys Partners
Operating partner at Asabys, Emilio joined the team in December 2024. Emilio supports our biopharma portfolio investments in strategy and business development and currently holds the CBO role at ALLOX.Previously, Emilio led external innovation deals at Boehringer Ingelheim, as Director of Global BD&L Oncology, contributing novel pipeline assets and technology platforms. Emilio has fostered pharma-biotech relationships across Europe, the US and Japan, and served as consultant for... Read More →
Speakers
avatar for Hakan Goker

Hakan Goker

Managing Director, Merck Ventures B.V.
Hakan Goker, PhD, is Managing Director of M Ventures and heads the Biotechnology Investments covering Healthcare and Life Sciences. Hakan joined M Ventures in 2013 and has been investing in the sector for 18 years. Previously, Hakan was a partner at Aescap Venture investing in European... Read More →
avatar for Marc Martinell

Marc Martinell

CEO, Minoryx Therapeutics
Marc Martinell is the founder and CEO of Minoryx Therapeutics, a Spanish biotechnology company specializing in the development of innovative treatments for rare diseases of the central nervous system (CNS). Martinell has also worked at other companies in the sector, such as Oryzon... Read More →
avatar for Alice Zhang

Alice Zhang

Senior Director Strategy, WuXi AppTec

avatar for Prabhu Velusami

Prabhu Velusami

Senior Director S&E EMEA, Johnson & Johnson
Dr Prabhu Velusami is Senior Director of New Ventures and Transactions for Johnson & Johnson Innovation and is located in the Innovation Centre in London. He leads the identification and sourcing of early stage transformative innovation, and the subsequent shaping and execution of... Read More →
Tuesday September 29, 2026 14:30 - 15:15 CEST
4 Raúl Martín room

15:15 CEST

Startup Pitch Presentations: Devices & Diagnostics
Tuesday September 29, 2026 15:15 - 15:45 CEST
Build high-impact investor pitches that translate medical-device and in vitro diagnostics innovation into clear financial potential and patient-outcome narratives investors can’t ignore.Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027. Debios Diagnostics — Joan Grasas, CeoManina Medtech — Mónica, Rodríguez...
See More →
Speakers
avatar for Joan Grasas

Joan Grasas

CEO, Debios Diagnostics
Joan Grasas is a catalyser of innovation and entrepreneurship. His background includes experience at the Institut Català de la Salut, the largest healthcare provider in Catalonia, and long-standing involvement with EIT Health. He has co-founded and led healthtech and IVD projects... Read More →
avatar for Mónica de la Vega

Mónica de la Vega

CEO, Manina Medtech
Monica is the co-founder and CEO of Manina Medtech. She has a Ph.D. in Biochemistry, 20+ years of research in life sciences, and a master's degree in Biodesign, Innovation, and Healthcare Entrepreneurship. Monica previously worked with RehaBeats, an online cardiac rehabilitation startup... Read More →
avatar for Nicolás López de Aguileta Castaño

Nicolás López de Aguileta Castaño

CTO, Oppotunitiy Health
Biomedical Engineer and CTO of Opportunity Health, a medtech company developing connected respiratory care solutions. Nicolás specializes in medical device development, regulatory strategy and healthcare innovation, with previous experience at the Navarra Health Service, BCN3D and... Read More →
avatar for Francesc Paris Huguet

Francesc Paris Huguet

CEO, Optec4Life

Tuesday September 29, 2026 15:15 - 15:45 CEST
4 Raúl Martín room

15:15 CEST

Advanced therapies and next-gen biotech platforms to deliver global health impact
Tuesday September 29, 2026 15:15 - 16:00 CEST
Advanced Therapies and Next-Gen Biotech Platforms to Deliver Global Health ImpactGiven the relative strength of the Basque Country in industrial biotechnology capabilities—particularly in advanced manufacturing, regenerative medicine, and translational research—this proposal envisions a coherent set of 2–3 interconnected BIOSPAIN 2026 sessions exploring advanced therapies and next-generation...
See More →
Moderators
avatar for Idoia Muñoz Lizán

Idoia Muñoz Lizán

Managing Director, Basque Health Cluster (BHC)

Speakers
JO

Julen Oyarzabal

CSO & Site Head, Artis Biosolutions

avatar for Virginia Arechavala

Virginia Arechavala

Group Leader Nucleic Acid Therapeutics, IIS Biobizkaia
Currently Works at the Neuromuscular Disorders Group, Biobizkaia Health Research Institute.Research line: Advanced therapies for neuromuscular disorders: antisense oligonucleotides, RNA therapy.Miguel Servet Fellowship I and II, Institute of Health Carlos III, Spain, 2013-2021... Read More →
avatar for Ander Izeta

Ander Izeta

Personalised Medicine and Advances Therapies director, IIS Biogipuzkoa/ Osakidetza/Basque Health Service
Head of a consolidated research group at the BioGipuzkoa Health Research Institute (IIS BioGipuzkoa) and director of the Personalized Medicine and Advanced Therapies Area at BioGipuzkoa. Head of the Advanced Therapies Unit at the Donostialdea Integrated Health Organization (OSI Donostialdea-Donostia... Read More →
avatar for Javier Alonso Gómez

Javier Alonso Gómez

General Manager, Litek Pharma

avatar for Jimmy Vanhove

Jimmy Vanhove

CEO, Viralgen
Jimmy Vanhove brings extensive experience in strategy, operational management, and digital transformation in the biotech/pharma industry. He has held various leadership positions with increased responsibility in manufacturing and strategy consulting at multinational companies like... Read More →
avatar for Julio Font

Julio Font

CEO, Histocell

Tuesday September 29, 2026 15:15 - 16:00 CEST
2 Dorotea Barnés room

15:15 CEST

AI and quantum computing in drug discovery: transforming molecular design and therapeutic development
Tuesday September 29, 2026 15:15 - 16:00 CEST
Quantum technologies are rapidly evolving from theoretical promise to practical tools across biomedicine and biotechnology. Early applications in drug discovery, molecular simulation, quantum enhanced imaging, and secure data infrastructures are already underway, supported by hybrid quantum–classical approaches and pioneering industrial collaborations. This panel will bring together experts from...
See More →
Moderators
avatar for Aitor Bergara

Aitor Bergara

Professor of Quantum Physics at UPV/EHU and Director of the EHU Quantum Center., University of the Basque Country

Speakers
avatar for David Hallett

David Hallett

Chief Scientific Officer, RECURSION

avatar for Ibai Díez Palacio

Ibai Díez Palacio

Assistant Professor of Radiology /Group coordinator CNS diseases & Computational Imaging, IIS Biobizkaia/Harvard Medical School
am an Instructor of Radiology with advanced neuroimaging, biomedical and computational expertise. My work has focused on developing cutting-edge neuroimaging methods and pipelines for multimodal neuroimage research. My research background combines a wide range of imaging techniques... Read More →
Tuesday September 29, 2026 15:15 - 16:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

15:15 CEST

Bizkaia, an entrepreneurial region: building instruments to boost strategic sectors
Tuesday September 29, 2026 15:15 - 16:00 CEST
Bizkaia has developed its own model for promoting strategic sectors, based, on the one hand, on the territory's capacity to design and activate advanced tax instruments, and on the other hand, on the creation of new financing vehicles that combine private contributions or facilitate access to cutting-edge enabling technologies. In this round table, representatives from the Bizkaia Provincial...
See More →
Moderators
avatar for Olatz Goitia Urquiaga

Olatz Goitia Urquiaga

General Director, BEAZ

Speakers
OU

Óscar Ugarte

General Manager, Seed Capital Bizkaia

VG

Valentín García

I+D Director, Lantik

avatar for Idoia Quintanilla

Idoia Quintanilla

Deputy Director of Inspection - Department of Finance, Diputación Foral de Bizkaia

Tuesday September 29, 2026 15:15 - 16:00 CEST
3 Nicolás Achúcarro room

16:00 CEST

AI Driving the Next Generation of Drug Development
Tuesday September 29, 2026 16:00 - 16:45 CEST
Artificial intelligence is reshaping every stage of the pharmaceutical innovation pathway, from the identification of novel therapeutic targets to clinical development, regulatory decision-making and patient access. The convergence of next-generation sequencing, integrative multi-omics, advanced machine learning and emerging European health data infrastructures is creating unprecedented...
See More →
Speakers
avatar for Antonio Fernández-Campa García-Bernardo

Antonio Fernández-Campa García-Bernardo

Manager, Health Knowledge Agency (ACIS)

GJ

Gonzalo Jiménez-Osés

Ikerbasque Research Professor & Principal Investigator, CIC bioGUNE

Tuesday September 29, 2026 16:00 - 16:45 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

16:00 CEST

Engineering the Materials of Life
Tuesday September 29, 2026 16:00 - 16:45 CEST
Engineered living materials (ELMs) are composed, either entirely or partly, of living cells. ELMs entirely composed of living cells are called biological ELMs and they self-assemble via a bottom-up process – e.g. synthetic morphogenesis for organoids’ production. ELMs only partly composed of living cells are called hybrid living materials (HLMs) and are built with a top-down process with...
See More →
Speakers
avatar for Manuel Salmeron Sanchez

Manuel Salmeron Sanchez

ICREA Research Professor / IBEC Director, IBEC (Institute for Bioengineering of Catalonia)
Manuel Salmerón-Sánchez es Profesor de Investigación ICREA y Director interino del Instituto de Bioingeniería de Cataluña (IBEC), cargo que asumió en enero de 2026. Es bioingeniero experto en biomateriales avanzados para ingeniería celular y medicina regenerativa.
Cargo act... Read More →
Tuesday September 29, 2026 16:00 - 16:45 CEST
3 Nicolás Achúcarro room

16:00 CEST

Making ATMPs Sustainable in 2026: What Gets Funded, Scaled, and Acquired?
Tuesday September 29, 2026 16:00 - 16:45 CEST
Following a market correction, ATMPs are entering a more selective phase where scientific promise must be matched by clear execution. This session will examine what differentiates companies that get funded, scaled, and ultimately acquired. The discussion will focus on investor selection criteria at seed and Series A, including data thresholds, platform differentiation, and capital efficiency. It...
See More →
Moderators
avatar for Robert Fabregat

Robert Fabregat

CEO, BIOCAT
Robert Fabregat (Barcelona, 1980) holds a degree in Chemistry and a PhD in Pharmacy from the University of Barcelona (UB), as well as a Master’s degree in Project Management from BES-La Salle and specific training in Strategy and Innovation from ESADE. From 2019 to 2021, he was... Read More →
Speakers
avatar for Francisco Borrego

Francisco Borrego

Ikerbasque Research Professor at Biobizkaia Health Research Institute, IIS Biobizkaia
I hold a Bachelor's and a Doctorate in Medicine and Surgery from the University of Córdoba. After completing my doctoral thesis, I worked for 18 years in the United States. The first 13 years were at the National Institutes of Health (NIH), and the following 5 years at the U.S. Food... Read More →
avatar for Anna Sanramón Giménez

Anna Sanramón Giménez

Manager, VINCES
Anna presta asesoramiento estratégico en asuntos públicos en el ámbito político, legislativo y social a empresas del sector de la salud.Antes de unirse a Vinces, realizó prácticas profesionales en el Ministerio de Asuntos Exteriores, Unión Europea y Cooperación. Posteriormente... Read More →
avatar for Avencia Sánchez Mejías

Avencia Sánchez Mejías

CEO & Co-founder, Integra Therapeutics
Proud to be leading Integra Therapeutics, a biotech company that is creating next-generation gene writing tools to boost the efficiency and safety of advanced therapies to cure genetic and oncological diseases with high unmet medical need.

I have a strong scientific background in

... Read More →
avatar for Jon Alberdi

Jon Alberdi

CEO, VIVEbiotech

avatar for Laura Rodríguez Gallego

Laura Rodríguez Gallego

Partner, Invivo Partners

Tuesday September 29, 2026 16:00 - 16:45 CEST
4 Raúl Martín room

16:00 CEST

Women’s health & care as a growing industry
Tuesday September 29, 2026 16:00 - 17:00 CEST
Women specificities in healthcare are gaining importance due to the higher socieconomical status in developed countries and insights from research highlighting sex and gender disparities in the development, prevention and treatment of diseases.As an example, cardiovascular disease remains the leading cause of death among women in the EU, yet it is still under-researched, frequently misdiagnosed,...
See More →
Speakers
avatar for María Amparo Valladares López

María Amparo Valladares López

Market Access Value Proposition & Government Affairs Lead, AbbVie

avatar for Eva Colás Ortega

Eva Colás Ortega

CSO & Founder, Mimark
I am the principal investigator of the Biomedical Research Group in Gynecology, where I lead the translational research group. My research focuses on providing solutions to unmet clinical needs in gynecology, primarily in endometrial cancer and endometriosis. We work on biomarker... Read More →
avatar for Marina Pollán

Marina Pollán

Director, Instituto de Salud Carlos III (ISCIII)
Marina Pollán holds a degree in Medicine from the University of Salamanca and is a specialist in Preventive Medicine and Public Health. She also studied at the Johns Hopkins School of Public Health (Baltimore, USA) and the Karolinska Institute (Stockholm, Sweden), and received the... Read More →
AV

Ane Vitoria

Scientific Advisory Board, Qassay Diagnostics/Welleo

avatar for Iván Macía Oliver

Iván Macía Oliver

Director of Digital Health & Biomedical Technologies, Vicomtech
- Vicomtech - Director of Digital Health and Biomedical Technologies (abbreviated Director of Health): This is my main role and the one that pays me. The biggest implication here is that I lead CARAMEL, a Horizon Europe project on Personalized Prevention in Women's Cardiovascular... Read More →
avatar for Carlos Escobar Cervantes

Carlos Escobar Cervantes

Cardiologist and co-founder Cofounder SAMIRA DTx, Hospital La Paz
Education: Bachelor of Medicine and Surgery from the Autonomous University of Madrid (1993-99). Doctor of Medicine from the University of Alcalá, awarded summa cum laude by unanimous decision (2007).

Professional Experience: Attending Physician in Cardiology at the Ramón y Cajal University Hospital in Madrid from 2006 to February 2008. Attending Physician in Cardiology at the Infanta Sofía University Hospital in San Sebastián de los Reyes, Madrid, from February 2008 to May... Read More →
Tuesday September 29, 2026 16:00 - 17:00 CEST
2 Dorotea Barnés room

16:45 CEST

Advancing Cell & Gene Therapies: Challenges, Innovation & Market Translation
Tuesday September 29, 2026 16:45 - 17:30 CEST
Cell and gene therapies (CGT) have revolutionised the treatment of many conditions and they continue to attract significant levels of investment. Their development faces unique challenges, ranging from technical complexity, regulation, scaling production, and the requirement of innovative commercialization models. This roundtable will explore how CGT can be effectively translated into innovation...
See More →
Moderators
avatar for James Cameron

James Cameron

Market Specialist for Cell & Molecular Research, Agilent NLD

Speakers
avatar for Carolina Pola

Carolina Pola

CEO, STAb Therapeutics
Multidisciplinary scientific professional with 12 years of experience in building relationships and communicating with different stakeholders in biomedicine including KOLs, foundations, science policy makers and business around the world. Expertise in identifying translational science... Read More →
avatar for Gaël Roué

Gaël Roué

Junior Group Leader, Josep Carreras Leukaemia Research Institute
Me doctoré en 2002 en la Universidad de Caen (Francia) y trabajé entre 2002 y 2004 como postdoc asociado en el Instituto Pasteur (París, Francia). Posteriormente me trasladé al Hospital Clínic de Barcelona (España) para trabajar en la caracterización de terapias nuevas y traslacionales... Read More →
avatar for Miguel Angel Campanero

Miguel Angel Campanero

Quality Control Manager, Syngoi Technologies
I am passionate about innovation, emerging technologies, and artificial intelligence, with a strong belief in the critical importance of quality systems in managing the lifecycle of medical products.

With 10 years of experience in quality system management, clinical evaluation, technical documentation development, auditing, and certification of medical and in-vitro diagnostic products, I co-founded A3Z Advanced in 2016, a boutique consulting firm that provides comprehensive support

... Read More →
Tuesday September 29, 2026 16:45 - 17:30 CEST
3 Nicolás Achúcarro room
 
Wednesday, September 30
 

09:30 CEST

Beyond Venture Capital Building Alternative Financing Pathways for Biotech Growth
Wednesday September 30, 2026 09:30 - 10:15 CEST
This round table will explore the growing range of alternative funding instruments available to innovative biotech SMEs, from public equity markets to emerging deeptech investment funds backed by public-private initiatives.Moderated by Óscar Salazar (Euro-Funding), the discussion will bring together representatives from BME Growth, ICO AXIS, and a listed Spanish biotech company to share practical...
See More →
Moderators
avatar for Oscar Salazar

Oscar Salazar

Managing Director European Funds, EURO FUNDING
Managing Director en la unidad de Fondos Europeos en Euro-Funding, donde lidera un equipo multidisciplinar de más de 30 profesionales internacionales, incluido el equipo de la oficina de Bruselas. Con casi tres décadas de trayectoria profesional, ha desarrollado una sólida carrera... Read More →
Speakers
avatar for Jesús González Nieto-Márquez

Jesús González Nieto-Márquez

Managing Director, BME Growth & BME Scaleup
Jesús González is the Managing Director of BME GROWTH and BME SCALEUP (the Spanish markets for SMEs), where more than 140 companies are traded, with a market capitalization exceeding €19 billion. He is also the Managing Director of Latibex, the Latin American Stock Exchange in... Read More →
avatar for Mercedes Storch

Mercedes Storch

FondICO Next Tech Director, AXIS Participaciones Empresariales SGEIC
More than 20 years linked to ICO/AXIS in different departments and a global point of view of ICO as development  bank. Currently FondICO Next Tech Investment Management and International Relations. Previously, in capital markets dep, involved in the structuration of ICO´s first... Read More →
avatar for Olatz Azpiazu Aguirre

Olatz Azpiazu Aguirre

Financial Manager, ELKARGI

avatar for Manuel Ramos

Manuel Ramos

CEO, LABIANA LIFE SCIENCES S.A.U.
Seasoned C-Suite Executive with 20 years of experience. My journey started as an Auditor and Consultant and took me to Senior Strategy and Private Banking.  I then moved on to Business Recovery Services in Restructuring and NPLs which took me to my current roles at Labiana where... Read More →
Wednesday September 30, 2026 09:30 - 10:15 CEST
4 Raúl Martín room

09:30 CEST

Biotech Act: Accelerating Biotech Scale-Up and Building Competitive Value Chains in Europe
Wednesday September 30, 2026 09:30 - 10:15 CEST
Following the publication of the proposed Biotech Act I Regulation, the European Commission has launched a consultation process for the future Biotech Act II, which will focus on industrial policy and on building a broad, forward-looking biotechnology ecosystem.In this session, organised by AseBio, we will examine the opportunities presented by Biotech Act II to advance biomanufacturing and...
See More →
Moderators
avatar for Ion Arocena

Ion Arocena

General Manager, AseBio

Speakers
avatar for Ana María Bravo

Ana María Bravo

Director of Public Affairs at IFF and President of Industrial Biotechnology Council Europabio, International Flavors & Fragance (IFF) / Europabio

avatar for Miguel Gómez-Pavón López

Miguel Gómez-Pavón López

Directorate-General for Industrial Strategy and Small and Medium-sized Enterprises (SMEs), Ministry of Industry and Turism
Industrial engineer from the ETSII-UPM with over 15 years of experience in the design and implementation of public policies, financial cooperation, and industrial strategy. My professional career has unfolded at the intersection of industry, innovation, and public action, with a common... Read More →
avatar for Kristin Schreiber

Kristin Schreiber

Director Chemicals, Bioeconomy and Retail, DG GROW.F, European Comission

Wednesday September 30, 2026 09:30 - 10:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

09:30 CEST

The Clinical Future of Bioprinting: From biofabrication technologies to next-generation regenerative therapies
Wednesday September 30, 2026 09:30 - 10:15 CEST
Bioprinting is rapidly evolving from an emerging laboratory technology into a transformative clinical platform with the potential to redefine regenerative medicine. This roundtable will bring together key European stakeholders from biofabrication, robotics, clinical translation and advanced manufacturing to discuss how bioprinting can successfully move from research environments into real-world...
See More →
Moderators
BO

Beatriz Olalde

Director of Healthcare Biomaterials, TECNALIA

Speakers
avatar for Anthony Remazeilles

Anthony Remazeilles

Medical Technology Researcher, TECNALIA
Anthony Remazeilles estudió ingeniería informática en el Institut National des Sciences Appliquées (INSA) en 2001, cuenta a su vez con máster en Informática e Inteligencia Artificial (Universidad de Rennes 1, 2001) y desde 2004 es doctor en ingeniería informática por la Universidad... Read More →
avatar for Begoña Ferrari

Begoña Ferrari

COO & Cofounder, COLFEED4PRINT S.L.
Scientific Researcher of CSIC at the Institute of Ceramic and Glass. She is in charge of R&D operations and the provision of human and economic resources to the team. At the CSIC, she is leading the research on the processing of complex ceramic and metallic composites by colloidal... Read More →
avatar for Francisco Miguel Sánchez Margallo

Francisco Miguel Sánchez Margallo

Scientific Director, Centro de Cirugía de Mínima Invasión Jesús Usón (CCMIJU)
Con más de 30 años de experiencia, el Dr. Sánchez Margallo es el Director Científico del Centro de Cirugía de Mínima Invasión Jesús Usón (CCMIJU), donde ha liderado importantes avances, como la participación del CCMIJU en el primer trasplante pulmonar robótico realizado... Read More →
JM

Jesús María Izco Zaratiegui

Bioproducts Diversification Manager, VISCOFAN
Dr. Jesús María Izco Zaratiegui is a prominent Spanish executive and scientist who serves as the Bioproducts Diversification Manager (Director General del Departamento de Diversificación) at Viscofan S.A., a global leader in casings for the food industry. 
Under his leadership... Read More →
LM

Luc Milbergue

President, POIETIS Biosistems
Luc Milbergue cuenta con experiencia previa en Strategir, Energies & Castors y Base Innovation. Fue Superintendente de Compañía de Burdeos entre 1983 y 1986. Posee una sólida trayectoria profesional que incluye desarrollo de nuevos negocios, ventas, desarrollo de productos, Microsoft... Read More →
Wednesday September 30, 2026 09:30 - 10:15 CEST
2 Dorotea Barnés room

10:15 CEST

Startup pitch presentations: Early stage companies
Wednesday September 30, 2026 10:15 - 10:45 CEST
Meet early stage companiesseeking seed/series A fundingAttendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.Backpacked-Antibody platform  – Izaskun Morillo, Postdoctoral ResearcherExitium Therapeutics  – Angélica Figueroa Conde-Valvís, CSOKorum Diagnostics  – Carla Ferrero Ruedas,...
See More →
Speakers
avatar for Izaskun Morillo

Izaskun Morillo

Postdoctoral Researcher, Backpacked-Antibody platform (EHU)
Izaskun is a postdoctoral researcher in the Antibody Engineering and Membrane Biophysics in Disease group at Biofisika Institute. Since 2021, my research has focused on improving monoclonal antibodies for cancer therapy by enhancing their cargo capacity. This work led to the development... Read More →
avatar for Angélica Figueroa Conde-Valvís

Angélica Figueroa Conde-Valvís

CSO, Exitium Therapeutics
Dra. Angélica Figueroa is a cancer researcher and innovation leader at INIBIC with more than 20 years of experience in molecular oncology, including work at international institutions such as the Medical Research Council-University College London, the National Institute on Aging... Read More →
avatar for Carla Ferrero Ruedas

Carla Ferrero Ruedas

CEO, Korum Diagnostics
CEO of Korum Diagnostics and PhD in Biotechnology specialized in infectious diseases and antimicrobial resistance (AMR). Background in translational research and early-stage technology transfer, developing rapid diagnostic solutions for clinical use. Focused on transforming scientific... Read More →
avatar for Guillem Loren

Guillem Loren

CEO, Lumina
Driving the development of novel light‑activated oncology therapies. PhD in Organic Chemistry and a Master's in Business Management in Biomedicine. My previous experience includes innovation management at a biotech spin-off and the design and synthesis of anticancer PROTACs.
avatar for Andrea Acebes Huerta

Andrea Acebes Huerta

CEO & Cofounder, Platelet Biotechnologies S.l.
Dr. Andrea Acebes Huerta is CEO and Co-founder of Platelet Biotechnologies and a scientist specialized in regenerative medicine and platelet-based therapies. She holds a PhD in Biochemistry from the University of Oviedo, awarded with International Mention and EMBO Fellowship recognition... Read More →
Wednesday September 30, 2026 10:15 - 10:45 CEST
4 Raúl Martín room

10:15 CEST

Biomanufacturing at an Inflection Point: Technology Breakthroughs, Scale-Up Challenges and the Future of the CMO Model
Wednesday September 30, 2026 10:15 - 11:00 CEST
This round table brings together perspectives from across the bioprocessing and biomanufacturing value chain. The discussion will explore major technological breakthroughs, including single-use systems, process intensification, automation, continuous bioprocessing, advanced analytics, AI and digitalization, while examining their real-world impact on process development and manufacturing. Speakers...
See More →
Speakers
avatar for Tom Manelius

Tom Manelius

Business Development Single-Use separation, Alfa Laval
I am a business driven engineer with a base in international sales development, marketing and sales support roles. I have also worked in Technology/Business Development, Product Management, Project Management and Consultancy positions. I truly enjouy working where business and technology... Read More →
avatar for Marcel de Matas

Marcel de Matas

Founder & Chief Business Officer, Seda Pharmaceutical Development & Clinical Manufacturing Services
Marcel is Founder and Chief Business Officer at Seda, a company focussed on delivering chemistry manufacturing and controls (CMC) and clinical pharmacology services. The company is located in Cheadle, Stockport and supports companies across UK, Europe, US, Asia and Australia.

Marcel has led the growth of technical capabilities and services at Seda, and has been instrumental in its transformation from a consultancy based business to an internationally recognised contract research, development, and manufacturing organisation. Services include the development

... Read More →
avatar for Natalia Serrano Morillas

Natalia Serrano Morillas

Key Account Manager, Celltoki
Professional with over 10 years of experience in health sciences, including the last 5 years in the biotech industrial sector. I have held roles in project and operations management related to the manufacturing of bioprocess equipment, with key responsibilities in planning, monitoring... Read More →
Wednesday September 30, 2026 10:15 - 11:00 CEST
3 Nicolás Achúcarro room

10:15 CEST

Regulating Intelligence: Bringing AI-Powered Medical Devices to the European Market under MDR and the AI Act
Wednesday September 30, 2026 10:15 - 11:00 CEST
Artificial intelligence is transforming medical devices, particularly software-based technologies for early disease detection and personalised healthcare. However, in 2026 AI-powered medical devices in Europe will operate under a dual regulatory framework shaped by Regulation (EU) 2017/745 (MDR) and the Artificial Intelligence Act, creating one of the most complex compliance environments...
See More →
Moderators
avatar for Itziar Alkorta Idiakez

Itziar Alkorta Idiakez

Professor, Euskal Herriko Unibertsitatea

Speakers
OB

Oskar Berreteaga Castro

QA & Compliance Manager, Irisbond Crowdbonding SL
Before my current position, I was CTO at Irisbond, Systems Engineering and Software Development Manager at ULMA Embedded Solutions, and a Researcher at Ikerlan. During my consulting work, I collaborated with several companies that had to comply with international standards including... Read More →
avatar for María Teresa Gómez Manzano

María Teresa Gómez Manzano

Medical Devices Iberia Manager/Medical Devices Lead Auditor, SGS
My professional career began in 2001, at the age of 23, as Quality and Environmental Manager at the multinational company PIMAN, with offices in Alcalá de Henares, Seville, Barcelona, ​​Poland, Morocco, and China, specializing in the metal sector.

Subsequently, in 2002, I joined the consulting firm Alta Calidad Consultores S.L., in the Quality, Environment, and Prevention Department. For the next four years, I held the position of junior consultant and later senior consultant. My responsibilities included providing legal advice... Read More →
avatar for Talyta Carteano

Talyta Carteano

Medical Devices Director., Asphalion
Talyta started at Asphalion as Medical Device Manager and Lead Auditor in 2020, bringing over 10 years’ experience in the Medical Devices field. She combines a technical background with a fulfilling career in the fields of regulatory affairs, quality management systems, devices development and leading people.She has proved to be key to the company since the very beginning thanks to her experience, which covers multiple... Read More →
Wednesday September 30, 2026 10:15 - 11:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

10:15 CEST

Translating Breakthroughs to Next‑Generation Therapies for ALS
Wednesday September 30, 2026 10:15 - 11:00 CEST
Amyotrophic Lateral Sclerosis (ALS) poses major scientific, clinical, and societal challenges. At the same time, unprecedented advances in molecular biology, drug discovery, biomarkers, precision medicine, and advanced therapeutic approaches are transforming the landscape of neurological research and care.This round table will bring together leading experts from academia, biotechnology, and...
See More →
Moderators
MS

Maite Solas

Vice-president, FUNDELA

Speakers
avatar for Manuel Cuervas-Mons Cantón

Manuel Cuervas-Mons Cantón

Medical Lead Innovative Medicines, Bristol Myers Squibb (BSM)
Medical Doctor, PhD, and board-certified surgeon with over 10 years of clinical experience in a tertiary hospital, where I led complex surgical cases and coordinated the Foot & Ankle Unit.

Driven by the ambition to improve patient outcomes beyond the operating room, I transitioned

... Read More →
avatar for Yosu Vara

Yosu Vara

Chemistry and Manufacturing Director, cofounder, Quimatriyx
He has 20 years of experience in the biotechnology and pharmaceutical industry, where he has managed drug discovery projects. He is the author of more than 20 patents and publications in organic chemistry.
He holds a PhD in Organic Chemistry from the University of the Basque Count... Read More →
avatar for Adolfo López de Munain

Adolfo López de Munain

Miramoon Pharma & SEED-ALS coordinator/leader, Osakidetza, IIS Biogipuzkoa, Miramoon Pharma
Dr. López de Munain is Chief Scientific Officer and Co-Founder of MiramoonPharma, with over 35 years of experience in clinical neurology, neurogenetics,and translational neuroscience. He holds an MD and a PhD in Medicine from theUniversity of Navarra, where he conducted his doctoral... Read More →
avatar for Ana Martínez Gil

Ana Martínez Gil

Cofounder & Scientific Advisory Board Member, Molefy Pharma
Experta en descubrimiento de fármacos y química medicinal, con más de 25 años de experiencia en enfermedades neurodegenerativas. Es profesora de investigación en el CIB-CSIC y cofundadora de Molefy Pharma.
Wednesday September 30, 2026 10:15 - 11:00 CEST
2 Dorotea Barnés room

11:00 CEST

Coffee break
Wednesday September 30, 2026 11:00 - 11:30 CEST

Wednesday September 30, 2026 11:00 - 11:30 CEST
2 Dorotea Barnés room

11:00 CEST

Coffee break
Wednesday September 30, 2026 11:00 - 11:30 CEST

Wednesday September 30, 2026 11:00 - 11:30 CEST
3 Nicolás Achúcarro room

11:00 CEST

Coffee break
Wednesday September 30, 2026 11:00 - 11:30 CEST

Wednesday September 30, 2026 11:00 - 11:30 CEST
4 Raúl Martín room

11:00 CEST

Coffee break
Wednesday September 30, 2026 11:00 - 11:30 CEST

Wednesday September 30, 2026 11:00 - 11:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:30 CEST

Fishing in the Atlantic Marine Biotech Innovation Ecosystem: from potential to societal impact
Wednesday September 30, 2026 11:30 - 12:15 CEST
Fishing in the Atlantic Marine Biotech Innovation Ecosystem: A Comprehensive Examination of Emerging Scientific and Technological Potential, Pathways for Development and Commercialization, Policy and Governance Challenges, and the Tangible Societal Impacts on Coastal Economies, Public Health, Biodiversity Conservation, and Community Resilience This expanded formulation frames a broad,...
See More →
Moderators
avatar for Elisabete da Costa

Elisabete da Costa

Scientific and Technological Advisor (PhD in Sustainable Chemistry), BLUEBIO ALLIANCE

Speakers
LC

Luís Costa

Chief Scientific and Sustainability Officer, A4F

avatar for Tiago H. Silva

Tiago H. Silva

Principal Researcher. Academic & Research Staff, University of Minho - Biomaterials, Biodegradables and Biomimetics Research Group.
PhD in Chemistry (Analytical Chemistry/Electrochemistry) - Universidade do Porto, 2006
 
Graduation in Chemistry (Analytical Chemistry) - Faculdade de Ciências da Universidade do Porto, 2001
 
Research Area:
MARINE INSPIRED BIOMATERIALS: Marine origin polymers and ceramics in Tissue Engineering; Valorization of marine resources and by-products; extraction/isolation and characterization of marine polymers (chitosan, collagen, fucoidan) and ceramics (calcium phosphates and biosilica); development... Read More →
avatar for Marta Conde Sieira

Marta Conde Sieira

Professor, Universidade de Vigo - Marine Research Center
Prof. Marta Conde-Sieira has developed her career in aquaculture, specializing in fish physiology, stress, and appetite regulation. After earning her PhD at the University of Vigo, she conducted postdoctoral research in Portugal, focusing on Senegalese sole and sustainable aquafeeds... Read More →
avatar for Ibon Cancio

Ibon Cancio

Full Professor, University of the Basque Country
Associate Professor in Cell Biology in UPV/EHU, accredited for Full Professorship by Spanish ANECA in May 2010 (positive answer of University for promotion July 2020). He has been coordinator of the official Masters degree in “Environmental Contamination & Toxicology” from 2012... Read More →
Wednesday September 30, 2026 11:30 - 12:15 CEST
3 Nicolás Achúcarro room

11:30 CEST

From Platform to Patient: Scaling Biotech and Advanced Therapies Through Integrated CDMO Ecosystems
Wednesday September 30, 2026 11:30 - 12:15 CEST
As biologics and advanced therapies—including proteins, antibodies, and ATMPs—reshape the therapeutic landscape, the key challenge is no longer only scientific, but industrial. This roundtable will explore how CDMOs are evolving beyond isolated capabilities into integrated, platform-driven ecosystems that accelerate development, reduce risk, and enable efficient path-to-patient.Rather than...
See More →
Moderators
avatar for Andreu Soldevilla

Andreu Soldevilla

CEO, Syna Therapeutics

Speakers
avatar for Natalia Elizalde

Natalia Elizalde

Chief Business Development Officer, Vivebiotech
Graduate in Pharmacy, she developed her end of degree project at UCLH Hospital in London. Afterwards, she was awarded a European PhD as a result of a thesis (University of Navarra; temporary stay at Oxford University) focused on the long-term effects of chronic mild stress over behaviour... Read More →
avatar for David Blanco

David Blanco

Managing Director, Leanbio

avatar for András Dinnyés

András Dinnyés

Co-founder and General Director, Biotalentum
Co-founder and general director of BioTalentum Ltd. He has been working on embryology, cryobiology, cloning and stem cell biology since 1985. He has been a Fulbright Scholar in the US in 1991-92 and worked at the University of Connecticut (US) for 1997-99, where he invented and patented... Read More →
Wednesday September 30, 2026 11:30 - 12:15 CEST
2 Dorotea Barnés room

11:30 CEST

The Role of Regional Ecosystems in Driving the Biotech Sector
Wednesday September 30, 2026 11:30 - 12:15 CEST
Regional biotechnology clusters and associations play a vital role in strengthening the biotechnology ecosystem by promoting collaboration among stakeholders, facilitating knowledge transfer, and accelerating the scientific and business development of the sector. Their work enhances the competitiveness of biotechnology companies while reinforcing the innovation and growth potential of their...
See More →
Speakers
avatar for Carlota Gómez de la Hoz

Carlota Gómez de la Hoz

Chief Corporate Affairs & Sustainability Officer, LABORATORIOS HIPRA S.A.

DA

Daniel Álvarez

International Development Manager, Bioga

ZP

Zara Pons Vila

Managing Director Biotechnological and Biomedical Cluster of the Balearic Islands – Gerent/Gerente, BIOIB - Clúster Biotecnològic i Biomèdic de les Illes Balears

avatar for Idoia Muñoz Lizán

Idoia Muñoz Lizán

Managing Director, Basque Health Cluster (BHC)

avatar for Robert Fabregat

Robert Fabregat

CEO, BIOCAT
Robert Fabregat (Barcelona, 1980) holds a degree in Chemistry and a PhD in Pharmacy from the University of Barcelona (UB), as well as a Master’s degree in Project Management from BES-La Salle and specific training in Strategy and Innovation from ESADE. From 2019 to 2021, he was... Read More →
avatar for Jesús Agüero González

Jesús Agüero González

Director, BIOVAL
I am a biologist with a PhD, and my research background includes a thesis in biotechnology. Using molecular biology tools, genetic engineering, and microscopy, we used a citrus virus to study its movement within the plant and introduced the instructions for it to express small pr... Read More →
Wednesday September 30, 2026 11:30 - 12:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:30 CEST

Startup Pitch Presentations: ATMP
Wednesday September 30, 2026 11:30 - 12:15 CEST
Meet innovative companies developing Advanced Therapy Medicinal Products, which are innovative drugs for human used based on genes, cells or tissue engineering.Start-ups will have the opportunity to present their business plans to a panel of investors. Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN...
See More →
Speakers
avatar for Laia Trigueros Motos

Laia Trigueros Motos

CEO, Amets Biotechnology
Solid track record in biomedical research and strategic leadership, resulting in impactful scientific solutions. Training in business management with the mission of guiding the clinical translation and international growth of Amets Biotechnology.
avatar for Jascha Blobel

Jascha Blobel

Founder & Chief Executive Officer, Golden Gait Biotech
Jascha Blobel is working since over 15 years in the development of biotech companies. Has has been involved in 3 out-licensing deals. As co-founder and CEO of Molomics Biotech, the company was sold to San Fransisco based VeriSIM Life in 2022. Jascha studied chemistry at the Ludwig-Maximilians... Read More →
avatar for Amalia Capilla

Amalia Capilla

CEO, Miramoon Pharma
Dr. Amalia Capilla is CEO of Miramoon Pharma and a biotech executive with 20+ years of experience in regenerative medicine, gene and cell therapy, and translational research. She holds a PhD in Molecular Biology from the University of Valencia and completed postdoctoral training at... Read More →
avatar for Miriam Corredor Sánchez

Miriam Corredor Sánchez

CEO, Nocturna Therapeutics
Miriam Corredor is CEO of NoctuRNA Therapeutics, a biotech company developing novel circular RNA therapeutics for neurodegenerative, neuromuscular and infectious diseases. She holds a PhD in Medicinal Chemistry in neurodegenerative diseases and a Master’s in Business Innovation... Read More →
avatar for Francesca Sarno

Francesca Sarno

CSO, Peaches S.L.
PhD in Biology with 15+ years of experience in translational oncology and advanced therapy development. Formerly involved in CNIO and hospital-based research, with 20+ scientific publications and experience coordinating European R&D projects. As Scientific Director at Peaches Biotech... Read More →
avatar for Iker Ausejo Mauleon

Iker Ausejo Mauleon

COO, Popcorn Therapeutics
Dr. Iker Ausejo Mauleon obtained his Ph.D. in applied medicine and biomedicine from the University of Navarra in 2023, complemented by international experience at the MD Anderson Cancer Center in Houston. Recognized as an emerging talent under 35 in Navarra, he has received 8 prestigious... Read More →
avatar for Ángel Lucio Pereira

Ángel Lucio Pereira

CEO, Tetraneuron S.L.
Angel Lucio is the CEO of Tetraneuron, a Spanish biotech company, advancing gene therapy solutions for Alzheimer’s disease and other neurodegenerative diseases. After several years supporting the company as an advisor and board member, Angel now leads its next phase of growth, as... Read More →
Wednesday September 30, 2026 11:30 - 12:15 CEST
4 Raúl Martín room

12:15 CEST

Can Cooperative Models Transform the Future of Pharma and Healthcare?
Wednesday September 30, 2026 12:15 - 13:00 CEST
What would it take to make cooperative enterprises viable at scale in the life sciences ecosystem? How can these models attract investment while preserving their core values? And could they unlock more resilient, inclusive, and patient-centered innovation systems? This roundtable will bring together leaders from healthcare, industry, policy, and cooperative movements to explore the opportunities...
See More →
Speakers
avatar for Raúl Pérez

Raúl Pérez

Scientific Director, I+Med.

avatar for Manuel Sánchez-Lagarejo

Manuel Sánchez-Lagarejo

General Manager, Bexen Medical & Bexen Bioservices

Wednesday September 30, 2026 12:15 - 13:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

12:15 CEST

From Lab to Market: Financing Spain’s Deep-Tech Future through Innvierte & Tech Transfer and the EIC Accelerator
Wednesday September 30, 2026 12:15 - 13:00 CEST
Spain is doubling down on early-stage innovation with the launch of the Innvierte Deep-Tech & Tech Transfer programme, led by CDTI Innovación under the Ministry of Science, Innovation and Universities (MICIU), in collaboration with the European Investment Fund. With a total allocation of €353 million targeting early-stage technologies (TRL 2–4), the initiative aims to address Spain’s...
See More →
Moderators
avatar for Ángel Sánchez

Ángel Sánchez

Partner, Science & Innovation Link Office (SILO)

Speakers
avatar for Myriam Rouis

Myriam Rouis

Senior Investment Manager/Advisor, EIC Fund - Venture Capital

avatar for Moisés Martín Carretero

Moisés Martín Carretero

General Director, CDTI

José Moisés Martín Carretero university degree in economics from the Universidad autónoma de Madrid and has extended graduate programs in finance from the IE Business School, Economic Analysis in the national and international economic relations in the CEPADE from Universidad... Read More →
avatar for Marc Ramis Castellfort

Marc Ramis Castellfort

Founder & Managing Partner, Montana
Marc is passionate about building ventures in the life sciences. He is co-Founder and Managing Partner of the Montana Children’s Health, a venture capital fund managed by Ship2B Ventures, where he focuses on creating and scaling companies dedicated to children’s health and pediatric... Read More →
avatar for Clara Campás

Clara Campás

Managing partner and co-founder of Asabys, Asabys Partners
Managing partner and co-founder of Asabys. Clara currently serves on the board of directors of Ona Therapeutics, Nuage Therapeutics, ALLOX and Augustine Therapeutics.Formerly, Clara served as Strategy & Development Director at Kern Pharma and held several positions at Advancell, including... Read More →
Wednesday September 30, 2026 12:15 - 13:00 CEST
4 Raúl Martín room

12:15 CEST

From Science to Market: The Value of Engineering Across the Biotech Product Lifecycle
Wednesday September 30, 2026 12:15 - 13:00 CEST
How early technical choices sculpt scalability, manufacturability, regulatory success and market readiness. Engineering doesn’t wait for shovels in the ground. It begins the moment a scientist chooses a route in the lab — a decision that can ripple through industrial design, regulatory strategy and the economic fate of a product. This roundtable will celebrate engineering as a continuous...
See More →
Moderators
avatar for Jordi Gibert Amat

Jordi Gibert Amat

Head of Biotechnology Unit, KLINEA
Experienced engineer with a demonstrated history of working in the Biotechnological and Pharmaceutical industry. Skilled in  R&D, innovation management, bioprocessing, process scale-up, process industrialization and GMP production.
Wednesday September 30, 2026 12:15 - 13:00 CEST
2 Dorotea Barnés room

12:15 CEST

New Approach Methodologies (NAMs): Accelerating Safer, Smarter and More Human-Relevant Innovation in Drug and Chemical Development
Wednesday September 30, 2026 12:15 - 13:00 CEST
New Approach Methodologies (NAMs) are transforming the way drugs, medical products, and chemicals are evaluated by providing more predictive, human-relevant, and sustainable alternatives to traditional testing approaches. By integrating advanced in vitro models, computational tools, artificial intelligence, in silico toxicology, and innovative preclinical strategies, NAMs offer new opportunities...
See More →
Moderators
avatar for Carmen Martín González

Carmen Martín González

CEO & Founder, CMG Meddev SL

Speakers
avatar for Natalia Sánchez

Natalia Sánchez

Senior Scientific Advisor, BeCytes Biotechnologies (BioIVT)

avatar for John Kendrick

John Kendrick

Executive Director, NAMs and Emerging Technologies, Labcorp
Over the past 20 years, I have worked diligently to build and refine my skills in Drug Development, with a particular focus on the scientific elements that make up DMPK. I have continued learning and evolving the skills for scientific and organizational leadership of this discipline... Read More →
avatar for Simón Perera del Rosario

Simón Perera del Rosario

Business Development Manager, ProtoQSAR
Simón. Simón Perera holds a degree in Biotechnology from the Autonomous University of Barcelona and a Master's degree in Biological Anthropology from the University of Barcelona.

He has worked as a project manager and business developer at various companies, including Anaxomics... Read More →
Wednesday September 30, 2026 12:15 - 13:00 CEST
3 Nicolás Achúcarro room

13:00 CEST

Lunch Break
Wednesday September 30, 2026 13:00 - 14:30 CEST

Wednesday September 30, 2026 13:00 - 14:30 CEST
2 Dorotea Barnés room

13:00 CEST

Lunch Break
Wednesday September 30, 2026 13:00 - 14:30 CEST

Wednesday September 30, 2026 13:00 - 14:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

13:00 CEST

Lunch Break
Wednesday September 30, 2026 13:00 - 14:30 CEST

Wednesday September 30, 2026 13:00 - 14:30 CEST
3 Nicolás Achúcarro room

13:00 CEST

Lunch Break
Wednesday September 30, 2026 13:00 - 14:30 CEST

Wednesday September 30, 2026 13:00 - 14:30 CEST
4 Raúl Martín room

14:30 CEST

Accelerating Oncology Innovation: Collaborative Models for Early Translation
Wednesday September 30, 2026 14:30 - 15:15 CEST
The successful translation of early-stage oncology research into therapies that reach patients requires more than scientific excellence. It demands effective collaboration among researchers, technology transfer professionals, biotech companies, patient organizations, investors, and funding institutions. As Europe increasingly embraces collaborative and impact-driven innovation models, new...
See More →
Moderators
avatar for Sofía Cabezudo

Sofía Cabezudo

Head of Innovation, Fundación Científica de la Asociación Española Contra el Cáncer

Speakers
avatar for Laureano Simón

Laureano Simón

CEO, Oncomatryx
Dr. Simón is the founder of Progenika Biopharma S.A. and co-founder of Progenika Inc., Proteomika S.L., and Abytnek Biopharma S.L. Dr. Simón has extensive experience in the diagnostics industry and has collaborated successfully with pharmaceutical companies.
Currently, Dr. Simón is the CEO of Progenika Group, co-CEO of Progenika Inc., and serves as a Director in biotechnology companies in Europe and the United States.He also advises various governments, scientific committees, public institutions, and private foundations on technology... Read More →
avatar for Arkaitz Carracedo

Arkaitz Carracedo

ERC Consolidator Grant Ikerbasque Research Professor Cancer Cell Signaling And Metabolism Lab, CIC Biogune
Arkaitz Carracedo obtained his BSc in Biology from the Complutense University of Madrid, and he continued his scientific pursuits by completing his PhD in Biochemistry and Molecular Biology at the same university. At this early stage in his career, he focused on researching the "... Read More →
avatar for Eider Sánchez

Eider Sánchez

Cofounder & CEO, Naru Intelligence Solutions S.L.

avatar for Fernando Aguirre

Fernando Aguirre

CEO, Hawk Biosystems
MSc in Physics, Fernando has more than 25 years of new business launch leadership across business development, internationalization and M&A, both as an entrepreneur (he has founded 5 companies so far) as well as in global management position in multinational companies such as Ericsson... Read More →
Wednesday September 30, 2026 14:30 - 15:15 CEST
2 Dorotea Barnés room

14:30 CEST

Advancing Transplant Innovation: Bridging Clinical Excellence with Smarter Drug Development
Wednesday September 30, 2026 14:30 - 15:15 CEST
A silent storm is sweeping the globe: chronic kidney failure touches more than 850 million lives, ranks ninth among causes of death, and affects roughly 10% of the world’s population. In Spain alone, 15% of adults live with chronic kidney disease and about 68,000 people require dialysis or transplant to survive. Spain stands out as a beacon of transplant medicine — performing more than 6,000...
See More →
Moderators
avatar for Pedro Carrascal

Pedro Carrascal

General Director, Platform of Patient Organisations
I have been involved with the multiple sclerosis movement since I was 8 years old, when my mother was diagnosed with MS. At that time, she and others founded the Bizkaia Association. I served as director of ADEMBI (Bizkaia Multiple Sclerosis Association) for 25 years (until 2022... Read More →
Speakers
avatar for Tabikh Ammar

Tabikh Ammar

Senior Medical Director, Clinical Development Global Medical Lead - Medical Strategy -Nephrology, CTI Clinical Trial & Consulting
As a Physician and Senior Medical Director in Clinical Development, I bring extensive experience leading global clinical programs across nephrology, transplantation, rare diseases, immunology, and metabolic disorders. Throughout my career, I have collaborated with sponsors, CROs... Read More →
avatar for Isabel Portero

Isabel Portero

CSO & Founder, Biohope
Isabel Portero (Salamanca, 1970) is the founder and CEO of Biohope, a startup dedicated to the creation and development of biomedical tests that allow for personalized medical treatment in diseases with an immunological basis. A Doctor of Medicine and specialist in Internal Medicine... Read More →
Wednesday September 30, 2026 14:30 - 15:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

14:30 CEST

Unlocking Opportunities in precision fermentation for the food industry
Wednesday September 30, 2026 14:30 - 15:15 CEST
Imagine a kitchen where tiny, tireless chefs—yeast, bacteria, or fungi—are taught new recipes at the molecular level. That is precision fermentation: a carefully controlled, biology-driven process that programs microorganisms to churn out specific food ingredients, from enzymes and flavor molecules to structurally complex proteins. Using modern genetic and metabolic engineering, these...
See More →
Speakers
JL

Jose Luis Moreno Carboneros

Business Development & Application Manager, COCOON

avatar for Laura Pedrós Manzanares

Laura Pedrós Manzanares

Business Developer, Levprot Bioscience

avatar for Guadalupe Monserrat Alvarado Jasso

Guadalupe Monserrat Alvarado Jasso

Researcher in culinary biotechnology, Basque Culinary Center/GOe Tech Center
I am a highly accomplished and strategic-minded professional with a Ph.D and a scientific approach to in managing research, development, and innovation projects, with extensive experience in leading multidisciplinary teams and optimizing resources. My scientific and strategic approach... Read More →
avatar for Ana Torrejón Cabello

Ana Torrejón Cabello

Head of Microbiology and Industrial Biotechnology, AINIA
Chemical Engineer (Polytechnic University of Valencia, 2006) and Master in Agri-food Biotechnology (University of Valencia, 2019).She is currently the Head of Microbiology and Industrial Biotechnology at AINIA. She has over ten years of experience in scaling up biotechnological processes... Read More →
Wednesday September 30, 2026 14:30 - 15:15 CEST
3 Nicolás Achúcarro room

15:15 CEST

Circularity at Scale: The 2030 Value Chain Challenge
Wednesday September 30, 2026 15:15 - 16:00 CEST
The European Union has positioned the bioeconomy as a cornerstone of its competitiveness, sustainability, and strategic autonomy agenda. The recently launched Strategy for a Competitive and Sustainable EU Bioeconomy seeks to accelerate the transition from innovation to industrial deployment by removing regulatory barriers, scaling investment, creating lead markets for bio-based solutions, and...
See More →
Moderators
avatar for Lara Valentín

Lara Valentín

Senior Innovation Consultant & Team Leader Circular Bioeconomy, PNO Innovation
I transform ideas into real and profitable innovation projects. I have been working in research and innovation for 20 years. The first 10 years my research was about contaminants and technologies to treat polluted sites. Since 2014 I have been dedicated to management and development... Read More →
Speakers
avatar for Armando Menéndez Estrada

Armando Menéndez Estrada

R&D&I Project Manager, ASINCAR

avatar for David San Martín Errea

David San Martín Errea

Senior Researcher, AZTI
Bachelor of Science in Biology from the University of Santiago de Compostela (USC); Advanced Technician in Aquaculture Production from the Institute of Agricultural and Fisheries Research and Training (IGA.FA); and Advanced Technician in Occupational Risk Prevention from Juritecn... Read More →
Wednesday September 30, 2026 15:15 - 16:00 CEST
3 Nicolás Achúcarro room

15:15 CEST

Current innovation trends in therapeutic technologies and modalities: what is the potential of Spain to ride these waves?
Wednesday September 30, 2026 15:15 - 16:00 CEST
Mapping where the next therapeutic breakthroughs are emerging in Spain—key institutions, technologies and talent—and how to access and translate them into investment and company-building opportunities. A guided tour of Spain’s biomedical frontier: where tomorrow’s therapies are being born, who’s driving them, which technologies enable them, and how to convert those breakthroughs into...
See More →
Moderators
avatar for Montserrat Vendrell

Montserrat Vendrell

Partner, Asabys Partners
Montse currently serves on the board of directors of Ona Therapeutics, InBrain Neuroelectronics, Peptomyc and Accure. She is also independent director at the board of Oryzon genomics.Formerly, Montse was partner at Aliath Bioventures and Alta Life Sciences. Prior to that, she was... Read More →
Speakers
avatar for Gloria González

Gloria González

Researcher / CSO, CIMA / Amets Biotechnology
She holds a degree in Biology from the University of the Basque Country. She earned her PhD from the Autonomous University of Madrid after completing her doctoral thesis at the Center for Biological Research (CBI) of the Spanish National Research Council (CSIC) in Madrid, under the... Read More →
avatar for Pilar Carrato

Pilar Carrato

Director of finance and innovation, CDTI
She began her professional career as a financial analyst at the Bank of Spain.

Subsequently, she developed her financial career in various securities and stock exchange firms in their international departments for 12 years, eventually becoming Head of Sales and Trading at BCH and... Read More →
avatar for Robert Fabregat

Robert Fabregat

CEO, BIOCAT
Robert Fabregat (Barcelona, 1980) holds a degree in Chemistry and a PhD in Pharmacy from the University of Barcelona (UB), as well as a Master’s degree in Project Management from BES-La Salle and specific training in Strategy and Innovation from ESADE. From 2019 to 2021, he was... Read More →
avatar for Gurutz Linazasoro

Gurutz Linazasoro

Founder, VIVEbiotech
Gurutz es neurólogo especializado en enfermedad de Parkinson y trastornos neurodegenerativos. Es Director del Programa de Terapias Avanzadas para el Alzheimer y Parkinson del Grupo Quirón Salud-Policlínica Gipuzkoa, y Director del Curso Nacional Anual sobre Trastornos del Movimiento.Gurutz... Read More →
Wednesday September 30, 2026 15:15 - 16:00 CEST
2 Dorotea Barnés room

15:15 CEST

Substance Matters: From Microbiome Breakthroughs to EU Benchmarks
Wednesday September 30, 2026 15:15 - 16:00 CEST
Human-derived substances are at the forefront of a new wave of biomedical innovation, spanning cell therapies, microbiome-based interventions, and advanced medicinal products. As these technologies rapidly evolve, so too does the complexity of the regulatory landscape governing their development and clinical application within the European Union. This session will explore the scientific, clinical,...
See More →
Speakers
avatar for Claudio Hidalgo Cantabrana

Claudio Hidalgo Cantabrana

CEO, Microviable Therapeutics
Co-founder and CEO at Microviable Therapeutics. Claudio obtained his PhD at the University of Oviedo (2015) focused on microbial genetics, probiotics and microbiome, after MS Biotechnology and BS Biology. Claudio has worked in several research international organizations across Europe... Read More →
avatar for María José Reyes

María José Reyes

Regional Regulatory Regional Director Europe, Clarke y Modet
At Clarke Modet my focus as Regulatory Consulting Director Europe is provide to our customers with Regulatory and Quality strategies and solutions for medicines and Medical devices to distribute pharmaceutical and Medical devices. With an extensive background in regulatory affairs... Read More →
avatar for Dominika Misztela

Dominika Misztela

Director Global Regulatory Science, Policy, and Intelligence Europe, CSL Behring
Highly motivated, ambitious, and skilled multilingual professional with demonstrated expertise in regulatory affairs and clinical project management and across EU and non-EU countries. 

Excellent knowledge of European research structures and frameworks and extensive regulatory ex

... Read More →
avatar for Patricia del Río

Patricia del Río

Executive Director, Mikrobiomik
Con más de tres años de trayectoria en Mikrobiomik, Patricia ha sido una pieza clave en su crecimiento, comenzando como Responsable de Ensayos Clínicos y más recientemente como Directora de Desarrollo de Negocios e Innovación.
Antes de unirse a Mikrobiomik, Patricia lider... Read More →
Wednesday September 30, 2026 15:15 - 16:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

15:15 CEST

Startup Pitch Presentations: Drug Development & Delivery
Wednesday September 30, 2026 15:15 - 16:30 CEST
Each company will be given a six-minute spotlight to unveil investment opportunities in drug development and delivery—six minutes to ignite interest and sketch the future of medicine.Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.Vaxdyn – Juan José Infante Viñolo, CEOFatrixGel  – Pablo...
See More →
Speakers
avatar for Juan José Infante Viñolo

Juan José Infante Viñolo

CEO, Vaxdyn
Dr. Infante leads Vaxdyn and its international collaboration network, advancing vaccines against antibiotic-resistant bacteria. As co-inventor of the company's core technology, he has secured funding from CARB-X, the European Commission and specialist investors. His background combines... Read More →
avatar for Pablo Sanchez-rey

Pablo Sanchez-rey

CEO & Founder, FatrixGel
Biologist and biotechnologist with a PhD in Biological Sciences and over 10 years of experience in the startup ecosystem. Former COO of a Fermentation Biotech, leading operations, strategic execution, and stakeholder relations. Currently CEO and founder of Fatrix Biotech, a biomaterial... Read More →
avatar for Ariadna Boloix Amenós

Ariadna Boloix Amenós

CEO & Co-founder, Flavii Therapeutics
Dr. Ariadna Boloix Amenós is CEO & Co-founder of Flavii Therapeutics S.L., leading corporate strategy and business development. She holds a PhD in Biochemistry and Biomedicine (UAB) and a Pharmacy degree (UB). Her research at the Vall d’Hebron Research Institute and Institute of Materials Science of Barcel... Read More →
avatar for Meritxell Teixidó Turà

Meritxell Teixidó Turà

Ceo & Cso, Gate2brain
Meritxell Teixidó holds a PhD in Organic Chemistry from the University of Barcelona and an eMBA from UOC. She spent more than 15 years at IRB Barcelona leading research on peptides capable of crossing biological barriers, co-supervising 10 PhDs, publishing over 50 scientific articles... Read More →
avatar for Andrea Zapater Matute

Andrea Zapater Matute

R&D Business Developer, i+Med S.coop
Andrea Zapater, PhD, is an R&D Business Development Manager at i+Med, focused on advanced biomaterials and drug delivery technologies for innovative therapeutic applications. She holds a PhD in Personalized Medicine and has experience in biotechnology, translational research, and... Read More →
avatar for Jessika Valero Gonzalez

Jessika Valero Gonzalez

Business Director, Mimo Biosciences
Jessika Valero González, PhD, leads Business Development and Strategy at MIMO Biosciences, where she drives growth, strategic partnerships, and market expansion. With extensive experience in biotechnology innovation and commercialization, she focuses on connecting breakthrough science... Read More →
avatar for Nicolás Galmarini

Nicolás Galmarini

CEO & Co-founder, Nanogrow Biotech
Economist and MBA with over 20 years in the pharmaceutical industry and a proven track record in establishing businesses across Latin America. Holds a BA in Economics from UdelaR and an MBA from Universidad Austral (Argentina). His extensive experience and entrepreneurial mindset... Read More →
avatar for Marie-eve Beaulieu

Marie-eve Beaulieu

General Manager, Nostrum Biodiscovery
Marie-Eve Beaulieu, PhD is General Manager of Nostrum Biodiscovery, a Barcelona- and Boston-based computational drug discovery technology company developing physics-based AI platforms for therapeutic design. She brings over 15 years of experience spanning drug discovery and executive leadership in biotech. Pr... Read More →
avatar for Angel Cebolla Ramírez

Angel Cebolla Ramírez

CEO, Olavide Neuron STX S.L. (ONESTX)
Dr. Ángel Cebolla is a scientist and serial bioentrepreneur with more than 25 years of experience translating academic research into profitable biotech solutions. After founding Biomedal and leading its world-class rapid food diagnostics division to a successful exit with the US... Read More →
avatar for Adolfo Gastalver

Adolfo Gastalver

Co-Founder & CEO, Ploid AI Biotech
Co-Founder & CEO of Ploid AI. Computer and electrical engineer specialized in AI, with two Master's degrees and a PhD candidacy in electrical engineering. Former AI researcher at CSIC-IIIA, with startup and consulting experience at Ingelectus and BCG.
avatar for Tania Ortuño

Tania Ortuño

Head of Operations, Molefy Pharma SL
Tania Ortuño is a biologist and doctor in Neuroscience with extensive experience combining scientific R&D with business development skills in innovation-driven environments. Her career spans neuroscience research and biotech operations, giving her a multidisciplinary profile at the... Read More →
avatar for Ignacio Massone

Ignacio Massone

CEO & Co-founder, Resistia
Former Big Pharma leader with a proven track record in business development and product launches. Currently Co-founder and CEO of Resistia, a deep-tech startup developing microbiome-derived therapies that restore the efficacy of existing antibiotics against resistant infections.

... Read More →
Wednesday September 30, 2026 15:15 - 16:30 CEST
4 Raúl Martín room

16:00 CEST

One Health Diagnostics: Rapid Detection and Characterization of Multidrug Resistant Bacteria to Enable Next Generation Antimicrobials
Wednesday September 30, 2026 16:00 - 16:45 CEST
Imagine a crossroads where human health, animal welfare, and the environment meet — and a new generation of sentinels stands guard. This panel will convene those sentinels to tackle the urgent challenge of protecting vulnerable people and animals from disease driven by major antibiotic‑resistant threats, and to showcase the bleeding‑edge tools that spot and dissect multidrug‑resistant...
See More →
Moderators
avatar for Raquel Carnero

Raquel Carnero

Senior Medical Devices Specialist, IQVIA

Speakers
avatar for Juan José Infante Viñolo

Juan José Infante Viñolo

CEO, Vaxdyn
Dr. Infante leads Vaxdyn and its international collaboration network, advancing vaccines against antibiotic-resistant bacteria. As co-inventor of the company's core technology, he has secured funding from CARB-X, the European Commission and specialist investors. His background combines... Read More →
avatar for Larraitz Añorga Gómez

Larraitz Añorga Gómez

Director of Research and Development, Biolan Health SL
R&D Director with a strong scientific background and more than 15 years of experience leading R&D&i projects focused on the design, development, and manufacturing of (bio)sensors (lateral flow immunoassays, electrochemical biosensors based on printing technologies, etc.) for food... Read More →
avatar for Santos Merino

Santos Merino

Senior Researcher & Surface Chemistry and Nanotechnology Unit, TEKNIKER

PhD in Solid State Physics in 1997. Since 2001, he was Head of the Micro and Nanofabrication Unit in IK4-Tekniker and since 2017 he is Head of the Sensors Research Area in the Surface Chemistry and Nanotechnologies Unit. He has worked on different fields such as in-vitro diagnostic tra... Read More →
avatar for Bruno González-Zorn

Bruno González-Zorn

Head of Antimicrobial Resistance Unit and Prof at UCM, Universidad Complutense de Madrid (UCM)
Bruno González Zorn, is a prominent microbiologist, scientist, and professor. He is recognized for his pioneering contributions to One Health and antimicrobial resistance (AMR). His work has had a significant impact on the global understanding of zoonotic diseases and the development... Read More →
Wednesday September 30, 2026 16:00 - 16:45 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

16:00 CEST

Blue Tools Final Infoday
Wednesday September 30, 2026 16:00 - 17:30 CEST

Wednesday September 30, 2026 16:00 - 17:30 CEST
3 Nicolás Achúcarro room

16:30 CEST

MythBusters: The Realities of Biotech Capital
Wednesday September 30, 2026 16:30 - 17:15 CEST
Speakers
avatar for Avencia Sánchez Mejías

Avencia Sánchez Mejías

CEO & Co-founder, Integra Therapeutics
Proud to be leading Integra Therapeutics, a biotech company that is creating next-generation gene writing tools to boost the efficiency and safety of advanced therapies to cure genetic and oncological diseases with high unmet medical need.

I have a strong scientific background in

... Read More →
avatar for Malgorzata Rogalska

Malgorzata Rogalska

Analyst, Ysios Capital

Wednesday September 30, 2026 16:30 - 17:15 CEST
4 Raúl Martín room

16:45 CEST

From Biotechnology to Clinical Intelligence: How to Build Biotech Solutions Powered by Software and AI, Interoperable by Design in Europe. Practical case: use in histopathology for biomarker identification
Wednesday September 30, 2026 16:45 - 17:30 CEST
The integration of biotechnology, software, and artificial intelligence is redefining the development of advanced solutions for diagnosis, patient stratifica on, and precision medicine. However, the effective transla on of these innovations into the European clinical environment requires going beyond analytical performance or the experimental validation of biomarkers. It also requires the ability...
See More →
Moderators
avatar for Carmen Martín González

Carmen Martín González

CEO & Founder, CMG Meddev SL

Speakers
avatar for María Teresa Gómez Manzano

María Teresa Gómez Manzano

Medical Devices Iberia Manager/Medical Devices Lead Auditor, SGS
My professional career began in 2001, at the age of 23, as Quality and Environmental Manager at the multinational company PIMAN, with offices in Alcalá de Henares, Seville, Barcelona, ​​Poland, Morocco, and China, specializing in the metal sector.

Subsequently, in 2002, I joined the consulting firm Alta Calidad Consultores S.L., in the Quality, Environment, and Prevention Department. For the next four years, I held the position of junior consultant and later senior consultant. My responsibilities included providing legal advice... Read More →
avatar for Valery Naranjo

Valery Naranjo

CTO, ARTIKODE
Experience as professor, researcher and director of CVBLab. Cordination of European projects. Innovation awards, Technology Transfer to Industry.
Catedrática de Teoría de la Señal. Universidad Politécnica de Valencia. Directora de CVBLab. Área de investigación: inteligencia artificial, análisis de imagen, visión por computador, análisis de señal... Read More →
avatar for Anna Rosés

Anna Rosés

Head of Innovation, Hospital Clínic de Barcelona
I lead innovation with a clear focus: turning complex ideas into execution and real-world impact.

My career spans private sector, entrepreneurship and healthcare, across multinational companies, startups and innovation-driven environments. This path has shaped how I work: combining strategic thinking with a strong execution mindset, moving comfortably in ambiguity, aligning diverse... Read More →
MM

Marta Montilla

Senior Global Quality & Regulatory Affairs Leader, CMG MedDev
Quality and Regulatory Leader with 12+ years of international experience in healthcare and in-vitro diagnostics (IVD), integrating R&D, quality, and regulatory frameworks. Skilled in translating complex regulations into internal policies, implementing operational digital systems... Read More →
Wednesday September 30, 2026 16:45 - 17:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

16:45 CEST

Rare Diseases at a Turning Point: From Gene Editing to Precision Medicines
Wednesday September 30, 2026 16:45 - 17:30 CEST
Rare disease research is entering a transformative era. Advances in precision medicine, in vivo gene editing and novel therapeutic modalities are opening unprecedented opportunities to address conditions that have long lacked effective treatments. However, scientific innovation alone is not sufficient. Translating breakthrough discoveries into accessible therapies requires overcoming significant...
See More →
Speakers
avatar for Óscar Millet

Óscar Millet

Group Leader Precision Medicine and Metabolism Lab, Atlas Molecular Pharma
I hold a Bachelor's degree in Chemistry (Ramon Llull University, 1994) and a Bachelor's degree in Chemical Engineering (IQS, 1995). After obtaining a PhD in Organic Chemistry (University of Barcelona, ​​1999), I joined Lewis Kay's group in Toronto for a postdoctoral fellowship... Read More →
avatar for María Fernández Jiménez

María Fernández Jiménez

Value, Access & Policy Director, AMGEN

avatar for Inmaculada Gilaberte Asin

Inmaculada Gilaberte Asin

Global Head Clinical Research Department, FAES Farma
PERSONAL PROFILE
o    Growth Mindset
o    Prioritize patients’ needs in every aspect of clinical strategy and execution.
o    Lead with a diverse, team-oriented collaborative approach, fostering strong collaboration across global multidisciplinary teams
o    Deliver results



... Read More →
avatar for Amalia Capilla

Amalia Capilla

CEO, Miramoon Pharma
Dr. Amalia Capilla is CEO of Miramoon Pharma and a biotech executive with 20+ years of experience in regenerative medicine, gene and cell therapy, and translational research. She holds a PhD in Molecular Biology from the University of Valencia and completed postdoctoral training at... Read More →
Wednesday September 30, 2026 16:45 - 17:30 CEST
2 Dorotea Barnés room
 
Thursday, October 1
 

09:30 CEST

From Lab Coats to Suits: Essential Roles in the Biotech Journey
Thursday October 1, 2026 09:30 - 10:15 CEST
· Moderación: Persona 
· Ponentes:
o Perfil I+D: David Álvarez Ordás (Roche)
o Perfil Manufacturing / Operations: Persona de 3P BIOVAN
o Perfil Regulatory Affairs: Persona de Viralgen
o Perfil Marketing: Persona de HIPRA

Thursday October 1, 2026 09:30 - 10:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

10:15 CEST

Magnetize & Maintain: Speeding up attraction, securing long-term retention
Thursday October 1, 2026 10:15 - 11:00 CEST
Mesa redonda 2: “Magnetize & Maintain: Speeding up attraction, securing long-term retention”
· Moderación: Persona de FEBiotec
· Ponentes:
o Perfil consultoría HR: Persona de otra consultora
o Perfil STEM: Persona de Bizkaia Talent
o Perfil formación: Persona de CESIF
o Perfil HR en empresa biotec: Paola Salanueva (Histocell)

Thursday October 1, 2026 10:15 - 11:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:00 CEST

Coffee break
Thursday October 1, 2026 11:00 - 11:30 CEST

Thursday October 1, 2026 11:00 - 11:30 CEST
2 Dorotea Barnés room

11:00 CEST

Coffee break
Thursday October 1, 2026 11:00 - 11:30 CEST

Thursday October 1, 2026 11:00 - 11:30 CEST
3 Nicolás Achúcarro room

11:00 CEST

Coffee break
Thursday October 1, 2026 11:00 - 11:30 CEST

Thursday October 1, 2026 11:00 - 11:30 CEST
4 Raúl Martín room

11:00 CEST

Coffee break
Thursday October 1, 2026 11:00 - 11:30 CEST

Thursday October 1, 2026 11:00 - 11:30 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

11:30 CEST

Unlocking the Lab: Navigating Patents and the Spin-off Landscape
Thursday October 1, 2026 11:30 - 12:15 CEST
· Moderación: Persona de FEBiotec
· Ponentes:
o Perfil patentes: Persona de Manuel Illescas
o Perfil inversor: Persona de Ysios Capital


Speakers
CI

Cristian Izquierdo

International Group Recruiter, PNO INNOVATION

avatar for Malgorzata Rogalska

Malgorzata Rogalska

Analyst, Ysios Capital

avatar for Teresa Riesgo Alcaide

Teresa Riesgo Alcaide

Secretary General for Innovation, Minstry of Science, Innovation and Universities
Professor of Electronic Technology at the Higher Technical School of Industrial Engineers of the UPM (ETSII-UPM), where she has developed her entire teaching and research career.Professional experienceShe has been director of the Center for Industrial Electronics, deputy director of Research and International Relations of the ETSII-UPM and, more recently, director of the Department of Automation, Electrical Engineering and Electronics and Industrial Informatics.Since 2003 she has... Read More →
avatar for Jascha Blobel

Jascha Blobel

Founder & Chief Executive Officer, Golden Gait Biotech
Jascha Blobel is working since over 15 years in the development of biotech companies. Has has been involved in 3 out-licensing deals. As co-founder and CEO of Molomics Biotech, the company was sold to San Fransisco based VeriSIM Life in 2022. Jascha studied chemistry at the Ludwig-Maximilians... Read More →
Thursday October 1, 2026 11:30 - 12:15 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

12:15 CEST

Job Opportunties of the Future: AI and the Digital Transformation of Biotech".
Thursday October 1, 2026 12:15 - 13:00 CEST
Moderación: Persona de una spin-off no elegida como ponenteo Perfil spin-off: BioComputing o HAWK Biosystems / Ubikare
o Perfil automatización: Persona de Agilent technologies
o Perfil uso IA para búsqueda fármacos: Persona de MSD
o Perfil uso IA en CDMO: Persona de Klinea

Speakers
LM

Lourdes Martínez Martínez

Director of Career Services, CESIF

Thursday October 1, 2026 12:15 - 13:00 CEST
1 Margarita Salas auditorium Azkue Kalea, 1, 48902 San Vicente de Barakaldo, Bizkaia

12:30 CEST

Passing the baton to Barcelona
Thursday October 1, 2026 12:30 - 13:00 CEST
With warm thanks to our regional hosts — the Provincial Government of Bizkaia and the Government of the Basque Country — we’re delighted to hand the baton to our friends from Catalonia, who will host the next edition of BIOSPAIN. See you in Barcelona for BIOSPAIN 2027!
Speakers
avatar for Ion Arocena

Ion Arocena

General Manager, AseBio

avatar for Robert Fabregat

Robert Fabregat

CEO, BIOCAT
Robert Fabregat (Barcelona, 1980) holds a degree in Chemistry and a PhD in Pharmacy from the University of Barcelona (UB), as well as a Master’s degree in Project Management from BES-La Salle and specific training in Strategy and Innovation from ESADE. From 2019 to 2021, he was... Read More →
avatar for Teresa Riesgo Alcaide

Teresa Riesgo Alcaide

Secretary General for Innovation, Minstry of Science, Innovation and Universities
Professor of Electronic Technology at the Higher Technical School of Industrial Engineers of the UPM (ETSII-UPM), where she has developed her entire teaching and research career.Professional experienceShe has been director of the Center for Industrial Electronics, deputy director of Research and International Relations of the ETSII-UPM and, more recently, director of the Department of Automation, Electrical Engineering and Electronics and Industrial Informatics.Since 2003 she has... Read More →
Thursday October 1, 2026 12:30 - 13:00 CEST
Biocat Booth #45
 
Share Modal

Share this link via

Or copy link

Filter sessions
Apply filters to sessions.